Genetic Technologies Limited (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 105   

Articles published

GENE 3.70 +0.01 (0.27%)
price chart
Genetic Technologies Limited soars 30%: Here's why
Genetic Technologies Limited (ASX: GTG) (�GTL�) has seen its share price soar another 30% today, after its ADR shares on NASDAQ surged 8% earlier this week and 36% overnight.
Genetic Technologies Limited (ADR) Analyst Rating Update  Stafford Daily
Genetic Technologies Limited (ADR) (NASDAQ:GENE): Did you Buy at $4.52 ...  US Market Buzz
Zacks Rating Disclosure on Genetic Technologies Limited (ADR)
Genetic Technologies Limited (ADR) (NASDAQ:GENE) is a hold, according to the latest average broker rating of 3. The number of analysts in this rating is 1. Research Analysts at Zacks has the counter a rating of 3, which implies that the firms ...
Genetic Technologies Limited (ADR) (NASDAQ:GENE) Sales Strategy To Focus ...  Inside Trade
Why gaining sharply? - Genetic Technologies Limited (ADR) (NASDAQ:GENE ...
Genetic Technologies Limited (ADR) (NASDAQ:GENE) rallied 17.16% in pre-market trading on Tuesday with no clear reason to point for the activity.
Biotech Sector's Sizzling Gainers Under Review - Signal Genetics ...  wsnewspublishers
Genetic Technologies Limited (ADR) (GENE): Fast-Growing Genetic ...
On August 1st, Genetic Technologies Limited (NASDAQ:GENE) announced a private placement of ordinary shares to domestic and overseas institutional and sophisticated investors to raise AUD 2.2M.
Related articles »  
Share Price of Genetic Technologies Limited (ADR) Rally 103.54%
Shares of Genetic Technologies Limited (ADR) (NASDAQ:GENE) rose by 103.54% in the past week and 348.54% for the past 4 weeks.
What Drives Genetic Technologies Limited (ADR) (NASDAQ:GENE)?  USMarketsDaily (blog)
Slipping Stocks: Genetic Technologies Limited (ADR) (GENE), E-House (China ...
Genetic Technologies Limited (ADR) (NASDAQ:GENE) decreased -9.09% and closed at $3.90 in the last trading session with the overall traded volume of 1.34 million shares, versus the average volume of 7.70 million shares.
Micro Cap Stocks News Review - Genetic Technologies (GENE), Altisource ...  Techsonian (press release)
Genetic Technologies Rises On Higher Sales of BREVAGen Breast Cancer Tests
Genetic Technologies Limited (GENE), a Melbourne, Australia-based genetics testing company announced today in a press release that it had received 1,096 patient samples for its BREVAGen breast cancer test in its latest quarter ended June 30.
Pharmaceutical Industry Updates: Eli Lilly and Co (NYSE:LLY), Genetic ...  Stocks.org
Related articles »  
Genetic Technologies Limited (ADR) Short Interest Update
Genetic Technologies Limited (ADR) (NASDAQ:GENE) Short interest is confirmed a change of 548.52% in the preceding 1-month.
Company Shares of Genetic Technologies Limited (ADR) Rally 41.58%
Shares of Genetic Technologies Limited (ADR) (NASDAQ:GENE) rose by 41.58% in the past week and 88.1% for the past 4 weeks.
MicroCap Stock's Buzzers: Genetic Technologies Limited (ADR) (GENE ...
Genetic Technologies Limited (ADR) (NASDAQ:GENE) decreased -3.60% and closed at $4.29 in the last trading session with the overall traded volume of 1.19 million shares, versus the average volume of 7.72 million shares.